Table III:
Baseline PRO Mayo 2012 Stage |
Number of patients (n) |
Mean score (S.D.) |
P-value |
---|---|---|---|
FACT-G Total Score | |||
I-II | 25 | 76 (17) | 0.36 |
III-IV | 18 | 71 (13) | |
FACT-G PWB score | |||
I-II | 26 | 19 (7) | 0.66 |
III-IV | 18 | 20 (5) | |
FACT-G SWB score | |||
I-II | 26 | 23 (4) | 0.43 |
III-IV | 18 | 22 (4) | |
FACT-G EWB score | |||
I-II | 25 | 17 (4) | 0.68 |
III-IV | 18 | 17 (5) | |
FACT-G FWB score | |||
I-II | 25 | 16 (6) | 0.020 |
III-IV | 18 | 11 (6) | |
PROMIS GPH T-score | |||
I-II | 9 | 42.0 (8.1) | 0.016 |
III-IV | 9 | 33.3 (4.7) | |
PROMIS GMH T-score | |||
I-II | 9 | 47.1 (7.3) | 0.10 |
III-IV | 9 | 41.6 (5.1) |
Abbreviations: PRO: Patient-reported outcome; SD: Standard deviation; FACT-G: Functional Assessment of Cancer Therapy-General; PWB: Physical Well Being; SWB: Social Well Being; EWB: Emotional Well Being; FWB: Functional Well Being; GPH: Global Physical Health; GMH: Global Mental Health; PROMIS: Patient-Reported Outcome Measurement Information System